142 related articles for article (PubMed ID: 10993595)
1. Mortality, cardiovascular events and risk factors in hypopituitarism.
Clayton RN
Growth Horm IGF Res; 1998 Feb; 8 Suppl A():69-76. PubMed ID: 10993595
[TBL] [Abstract][Full Text] [Related]
2. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
Tomlinson JW; Holden N; Hills RK; Wheatley K; Clayton RN; Bates AS; Sheppard MC; Stewart PM
Lancet; 2001 Feb; 357(9254):425-31. PubMed ID: 11273062
[TBL] [Abstract][Full Text] [Related]
3. Life expectancy following surgery for pituitary tumours.
Bates AS; Bullivant B; Sheppard MC; Stewart PM
Clin Endocrinol (Oxf); 1999 Mar; 50(3):315-9. PubMed ID: 10435056
[TBL] [Abstract][Full Text] [Related]
4. Premature mortality due to cardiovascular disease in hypopituitarism.
Rosén T; Bengtsson BA
Lancet; 1990 Aug; 336(8710):285-8. PubMed ID: 1973979
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrovascular mortality in patients with hypopituitarism.
Bülow B; Hagmar L; Mikoczy Z; Nordström CH; Erfurth EM
Clin Endocrinol (Oxf); 1997 Jan; 46(1):75-81. PubMed ID: 9059561
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in hypopituitarism.
Smith JC
Expert Opin Pharmacother; 2004 May; 5(5):1023-31. PubMed ID: 15155105
[TBL] [Abstract][Full Text] [Related]
7. The effect of hypopituitarism on life expectancy.
Bates AS; Van't Hoff W; Jones PJ; Clayton RN
J Clin Endocrinol Metab; 1996 Mar; 81(3):1169-72. PubMed ID: 8772595
[TBL] [Abstract][Full Text] [Related]
8. Hypopituitarism and mortality in pituitary adenoma.
Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
[TBL] [Abstract][Full Text] [Related]
9. [Impact of hormonal deficit and cardiovascular risk factors on life expectancy in hypopituitarism].
Ricart W; Fernández-Real JM
Med Clin (Barc); 2003 May; 120(16):630-7. PubMed ID: 12732130
[No Abstract] [Full Text] [Related]
10. Mortality in adults with hypopituitarism: a systematic review and meta-analysis.
Jasim S; Alahdab F; Ahmed AT; Tamhane S; Prokop LJ; Nippoldt TB; Murad MH
Endocrine; 2017 Apr; 56(1):33-42. PubMed ID: 27817141
[TBL] [Abstract][Full Text] [Related]
11. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results.
Erfurth EM; Bülow B; Eskilsson J; Hagmar L
Growth Horm IGF Res; 1999 Apr; 9 Suppl A():21-4. PubMed ID: 10429876
[TBL] [Abstract][Full Text] [Related]
12. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.
Burman P; Mattsson AF; Johannsson G; Höybye C; Holmer H; Dahlqvist P; Berinder K; Engström BE; Ekman B; Erfurth EM; Svensson J; Wahlberg J; Karlsson FA
J Clin Endocrinol Metab; 2013 Apr; 98(4):1466-75. PubMed ID: 23457412
[TBL] [Abstract][Full Text] [Related]
13. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.
Bülow B; Hagmar L; Eskilsson J; Erfurth EM
J Clin Endocrinol Metab; 2000 Feb; 85(2):574-84. PubMed ID: 10690858
[TBL] [Abstract][Full Text] [Related]
14. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
15. Mortality in patients with non-functioning pituitary adenoma.
Tampourlou M; Fountas A; Ntali G; Karavitaki N
Pituitary; 2018 Apr; 21(2):203-207. PubMed ID: 29344906
[TBL] [Abstract][Full Text] [Related]
16. Treatment Factors That Influence Mortality in Acromegaly.
McCabe J; Ayuk J; Sherlock M
Neuroendocrinology; 2016; 103(1):66-74. PubMed ID: 25661647
[TBL] [Abstract][Full Text] [Related]
17. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.
Esposito D; Ragnarsson O; Granfeldt D; Marlow T; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 May; 178(5):459-469. PubMed ID: 29483205
[TBL] [Abstract][Full Text] [Related]
18. Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.
Bengtsson BA
Growth Horm IGF Res; 1998 Feb; 8 Suppl A():77-80. PubMed ID: 10993596
[TBL] [Abstract][Full Text] [Related]
19. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
Colao A; Spiezia S; Di Somma C; Marzullo P; Cerbone G; Pivonello R; Faggiano A; Lombardi G
Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
[TBL] [Abstract][Full Text] [Related]
20. Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit.
Miljic D; Doknic M; Stojanovic M; Nikolic-Djurovic M; Petakov M; Popovic V; Pekic S
Endocrine; 2017 Nov; 58(2):312-319. PubMed ID: 28913704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
